Clinical study of Shenyuan Yiqi Huoxue Capsule on cardiopulmonary motor function and quality of life in patients with ischemic cardiomyopathy

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Meeting the diagnostic criteria of ischemic cardiomyopathy, and the TCM syndrome differentiation type belongs to Qi deficiency and blood stasis type.
•? Recent or previous echocardiography showed left ventricular ejection fraction (LVEF)<40%, NYHA cardiac function grade II-III.
•? Coronary angiography or CT showed multiple vessel stenosis, or a history of coronary revascularization, or a clear history of myocardial infarction.
•? Between the ages of 18 and 75.
•? Patients and family members gave informed consent and signed informed consent.

•? Other causes of heart failure or enlargement.
•? NYHA cardiac function grade IV.
•? Pregnant and lactation patients.
•? Severe cardiogenic shock and severe hypotension.
•? Severe anemia, coagulopathy.
•? Severe brain, liver, renal dysfunction, limb movement disorder;
•? The presence of allergy or hypersensitivity to the ingredients involved in the study drug.
•? Recently participated in clinical observation of other drugs or taken preparations similar to traditional Chinese medicine.
•If one of the above is combined, it is excluded from the group.

发起方

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University